Tactile Systems Technology Inc
NASDAQ:TCMD
Net Margin
Tactile Systems Technology Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Tactile Systems Technology Inc
NASDAQ:TCMD
|
331m USD |
6%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
228.5B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
180.6B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
147.4B USD |
11%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
144B USD |
13%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
114B USD |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
65.7B USD |
8%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
56.1B EUR |
9%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
42.4B USD |
77%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
273.8B CNY |
33%
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
36.3B USD |
10%
|
Tactile Systems Technology Inc
Glance View
Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Tactile Systems Technology Inc's most recent financial statements, the company has Net Margin of 5.8%.
You don't have any saved screeners yet